Comparison of safety and toxicity of liposomal doxorubicin vs. conventional anthracyclines: a meta-analysis

@inproceedings{Rafiyath2012ComparisonOS,
  title={Comparison of safety and toxicity of liposomal doxorubicin vs. conventional anthracyclines: a meta-analysis},
  author={Shamudheen Mohammed Rafiyath and Muhammad Rasul and Byung Ick Lee and Guoqing Wei and Gurpreet S Lamba and Delong Liu},
  booktitle={Experimental hematology & oncology},
  year={2012}
}
UNLABELLED BACKGROUND Liposomal formulations of anthracyclines appear to have favorable toxicity profile when compared with conventional anthracyclines in elderly, high risk cardiac patients and patients with prior use of anthracyclines. Randomized controlled trials have evaluated the efficacy and safety profile of liposomal formulations with conventional anthracyclines. Our aim is to evaluate the adverse effects and quantify the relative safety profile of the liposomal and conventional… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 1 time. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 39 extracted citations

Cardiotoxicity with carfilzomib at doses greater than 27 mg/m2: A case series.

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners • 2019

Cardio-oncology: an overview on outpatient management and future developments

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation • 2018

References

Publications referenced by this paper.
Showing 1-10 of 32 references

Similar Papers

Loading similar papers…